ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Wins Journalism Award

April 1, 2011

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981